Skeletal toxicities of treatment in children with cancer

Pediatric Blood and Cancer

Volumn 50, Issue 2 SUPPL., 2008, Pages 469-473

  Kaste, Sue C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Bone mineral density; Dual energy absorptiometry; Late effects; Osteonecrosis; Pediatrics; Quantitative computed tomography

Indexed keywords

AGING; BONE DENSITY; BONE MASS; BONE NECROSIS; CANCER SURVIVAL; CHILDHOOD CANCER; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FOLLOW UP; FRACTURE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PERTHES DISEASE; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

AGING; BONE DENSITY; CHILD; HUMANS; NEOPLASMS; OSTEONECROSIS; OSTEOPOROSIS;

EID: 37549025832     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21408     Document Type: Review

References (82)

1. Miller BA, Ries LAG, Bleyer WA, et al. SEER cancer statistics review: 1973-1990. Bethesda: National Cancer Institute; 1993.
2. Gilsanz V. Bone density in children: A review of the available techniques and indications. Eur J Radiol 1998;26:177-182.
3. Dorland's Illustrated Medical Dictionary. Philadelphia: WB Saunders; 1994.
4. El Hajj FG, Baddoura R, Awada H, et al. Practice guidelines on the use of bone mineral density measurements: Who to test? What measures to use? When to treat? A consensus report from the Middle East Densitometry Workshop. J Med Liban 2002;50:89-104.
5. Official Positions of the International Society for Clinical Densitometry. In: 2005. http://www.iscd.org/visitors/positions/official.
6. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 2006;194:S3-S11.
7. Cummings SR. Epidemiology of osteoporotic fractures. In: Genant HK, editor. Osteoporosis update 1987. San Francisco, CA: Radiology Research and Education Foundation; 1987. pp 7-12.
8. Kaste SC, Tong X, Hendrick JM, et al. QCT versus DXA in 320 survivors of childhood cancer: Association of BMD with fracture history. Pediatr Blood Cancer 2006;46:936-943.
9. Skaggs DL, Loro ML, Pitukcheewanont P, et al. Increased body weight and decreased radial cross-sectional dimensions in girls with forearm fractures. J Bone Miner Res 2001;16:1337-1342.
10. Goulding A, Cannan R, Williams SM, et al. Bone mineral density in girls with forearm fractures. J Bone Miner Res 1998;13:143-148.
11. Melton LJ III, Atkinson EJ, O'Fallon WM, et al. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 1993;8:1227-1233.
12. Landin LA. Fracture patterns in children. Analysis of 8,682 fractures with special reference to incidence, etiology and secular changes in a Swedish urban population 1950-1979. Acta Orthop Scand Suppl 1983;202:1-109.
13. Ma DQ, Jones G. Clinical risk factors but not bone density are associated with prevalent fractures in prepubertal children. J Paediatr Child Health 2002;38:497-500.
14. van der Sluis I, van den Heuvel-Eibrink MM, Hahlen K, et al. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 2002;141:204-210.
15. van der Sluis I, van den Heuvel-Eibrink MM, Hahlen K, et al. Bone mineral ensity, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 2000;35:415-420.
16. Hesseling PB, Hough SF, Nel ED, et al. Bone mineral density in long-term survivors of childhood cancer. Int J Cancer 1998;11:44-47.
17. Jones G, Ma D. Skeletal age deviation assessed by the Tanner-Whitehouse 2 method is associated with bone mass and fracture risk in children. Bone 2005;36:352-357.
18. Faulkner KG, Roberts LA, McClung MR. Discrepancies in normative data between Lunar and Hologic DXA systems. Osteoporos Int 1996;6:432-436.
19. Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res 1992;7:137-145.
20. Nevill AM, Holder RL, Maffulli N, et al. Adjusting bone mass for differences in projected bone area and other confounding variables: An allometric perspective. J Bone Miner Res 2002;17:703-708.
21. Kroger H, Kotaniemi A, Kroger L, et al. Development of bone mass and bone density of the spine and femoral neck - A prospective study of 65 children and adolescents. Bone Miner 1993;23:171-182.
22. Leonard MB. Dual energy X-ray absorptiometry: Shortcomings in the assessment of bone health in children. Calcif Tiss Int 2002;70:355-383.
23. Leonard MB. Assessment of bone health in children and adolescents with cancer: Promises and pitfalls of current techniques. Med Pediatr Oncol 2003;41:198-207.
24. Bachrach LK. Bare-bones fact - Children are not small adults. N Engl J Med 2004;351:924-926.
25. van Rijn RR, van dS I, Link TM, et al. Bone densitometry in children: A critical appraisal. Eur Radiol 2003;13:700-710.
26. Kaste SC, Shidler TJ, Tong X, et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant 2004;33:435-441.
27. Sklar CA, Mertens AC, Walter A, et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: Role of cranial irradiation. Med Pediatr Oncol 2000;35:91-95.
28. Bhatia S, Landier W. Evaluating survivors of pediatric cancer. Cancer J 2005;11:340-354.
29. Lerner SE, Huang GJ, McMahon D, et al. Growth hormone therapy in children after cranial/craniospinal radiation therapy: Sexually dimorphic outcomes. J Clin Endocrinol Metab 2004;89:6100-6104.
30. Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors of childhood cancer: A report from the childhood cancer survivor study. J Natl Cancer Inst 2006;98:890-896.
31. Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2006;91:1723-1728.
32. Laverdiere C, Cheung NK, Kushner BH, et al. Long-term complications in survivors of advanced stage neuroblastoma. Pediatr Blood Cancer 2005;45:324-332.
33. Punyko JA, Mertens AC, Gurney JG, et al. Long-term medical effects of childhood and adolescent rhabdomyosarcoma: A report from the childhood cancer survivor study. Pediatr Blood Cancer 2005;44:643-653.
34. Brownstein CM, Mertens AC, Mitby PA, et al. Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: A report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2004;89:4422-4427.
35. Sklar C. Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monogr 2005;34:25-27.
36. Sklar CA. Childhood brain tumors. J Pediatr Endocrinol Metab 2002;15:669-673.
37. Oberfield SE, Sklar CA. Endocrine sequelae in survivors of childhood cancer. Adolesc Med 2002;13:161-169, viii.
38. Sklar C, Boulad F, Small T, et al. Endocrine complications of pediatric stem cell transplantation. Front Biosci 2001;6:G17-G22.
39. Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 1999;33:2-8.
40. Sklar CA. Growth and neuroendocrine dysfunction following therapy for childhood cancer. Pediatr Clin North Am 1997;44:489-503.
41. Sklar C. Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Paediatr Suppl 1995;411:57-61.
42. Sklar CA. Growth following therapy for childhood cancer. Cancer Invest 1995;13:511-516.
43. Sklar CA. Growth and pubertal development in survivors of childhood cancer. Pediatrician 1991;18:53-60.
44. Krupa B, Miazgowski T. Bone mineral density and markers of bone turnover in boys with constitutional delay of growth and puberty. J Clin Endocrinol Metab 2005;90:2828-2830.
45. Boot AM, Muinck Keizer-Schrama S, Pols HA, et al. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty. J Clin Endocrinol Metab 1998;83:370-373.
46. Questions and Answers about Osteonecrosis (Avascular Necrosis). In: 2006. http://www.niams.nih.gov/hi/topics/osteonecrosis.
47. Scribner AN, Troia-Cancio PV, Cox BA, et al. Osteonecrosis in HIV: A case-control study. J Acquir Immune Defic Syndr 2000;25:19-25.
48. Brown P, Crane L. Avascular necrosis of bone in patients with human immunodeficiency virus infection: Report of 6 cases and review of the literature. Clin Infect Dis 2001;32:1221-1226.
49. Karimova EJ, Rai SN, Ingle D, et al. MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 2, clinical and imaging patterns. AJR Am J Roentgenol 2006;186:477-482.
50. Karimova EJ, Rai SN, Deng X, et al. MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 1, observer agreement. AJR Am J Roentgenol 2006;186:470-476.
51. Mattano LA, Jr., Sather HN, Trigg ME, et al. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: A report from the Children's Cancer Group. J Clin Oncol 2000;18:3262-3272.
52. Ribeiro RC, Fletcher BD, Kennedy W, et al. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia 2001;15:891-897.
53. Mata SG, Aicua EA, Ovejero AH, et al. Legg-Calve-Perthes disease and passive smoking. J Pediatr Orthop 2000;20:326-330.
54. Gaughan DM, Mofenson LM, Hughes MD, et al. Osteonecrosis of the hip (Legg-Calve-Perthes disease) in human immunodeficiency virus-infected children. Pediatrics 2002;109:E74.
55. National Osteonecrosis Foundation. In: 2006. http://www.nonf.org/ nofbrochure/nonf-brochure.htm.
56. Perthes Disease. In: 2006. http://orthoinfo.aaos.org/fact/thr_report.cfm? thread_id=159&topcategory=hip.
57. Ojala AE, Lanning FP, Paakko E, et al. Osteonecrosis in children treated for acute lymphoblastic leukemia: A magnetic resonance imaging study after treatment. Med Pediatr Oncol 1997;29:260-265.
58. LaPorte DM, Mont MA, Mohan V, et al. Multifocal osteonecrosis. J Rheumatol 1998;25:1968-1974.
59. Collaborative Osteonecrosis Group. Symptomatic multifocal osteonecrosis. A multicenter study. Clin Orthop Relat Res 1999;312-326.
60. Chollet CT, Britton L, Neel MD, et al. Childhood cancer survivors: An at-risk cohort for ankle osteonecrosis. Clin Orthop Relat Res 2005; 149-155.
61. Stulberg BN. Osteonecrosis: What to do, what to do. J Arthroplasty 2003;18:74-79.
62. Watson RM, Roach NA, Dalinka MK. Avascular necrosis and bone marrow edema syndrome. Radiol Clin North Am 2004;42:207-219.
63. Huang GS, Chan WP, Chang YC, et al. MR imaging of bone marrow edema and joint effusion in patients with osteonecrosis of the femoral head: Relationship to pain. Am J Roentgenol 2003;181:545-549.
64. Assouline-Dayan Y, Chang C, Greenspan A, et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002;32:94-124.
65. Steinberg ME. Early diagnosis, evaluation, and staging of osteonecrosis. Instr Course Lect 1994;43:513-518.
66. Steinberg ME, Hayken GD, Steinberg DR. A quantitative system for staging avascular necrosis. J Bone Joint Surg Br 1995;77:34-41.
67. Steinberg ME, Bands RE, Parry S, et al. Does lesion size affect the outcome in avascular necrosis? Clin Orthop Relat Res 1999; 262-271.
68. Steinberg ME, Steinberg DR. Classification systems for osteonecrosis: An overview. Orthop Clin North Am 2004;35:273-283, vii-viii.
69. Magnussen RA, Guilak F, Vail TP. Articular cartilage degeneration in post-collapse osteonecrosis of the femoral head. Radiographic staging, macroscopic grading, and histologic changes. J Bone Joint Surg Am 2005;87:1272-1277.
70. Sugano N, Atsumi T, Ohzono K, et al. The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head. J Orthop Sci 2002;7:601-605.
71. Kay RM, Lieberman JR, Dorey FJ, et al. Inter- and intraobserver variation in staging patients with proven avascular necrosis of the hip. Clin Orthop Relat Res 1994; 124-129.
72. Socie G, Selimi F, Sedel L, et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: Clinical findings, incidence and risk factors. Br J Haematol 1994;86:624-628.
73. Relling MV, Yang W, Das S, et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 2004;22:3930-3936.
74. Ribeiro RC, Fletcher BD, Kennedy W, et al. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia 2001;15:891-897.
75. Schulte CM, Beelen DW. Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: Diagnosis and gender matter. Transplantation 2004;78:1055-1063.
76. Arico M, Boccalatte MF, Silvestri D, et al. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 2003;88:747-753.
77. Wolfe CJ, Taylor-Butler KL. Avascular necrosis. A case history and literature review. Arch Fam Med 2000;9:291-294.
78. Koo KH, Kim R. Quantifying the extent of osteonecrosis of the femoral head. A new method using MRI. J Bone Joint Surg Br 1995;77:875-880.
79. Ohzono K, Saito M, Takaoka K, et al. Natural history of nontraumatic avascular necrosis of the femoral head. J Bone Joint Surg Br 1991;73:68-72.
80. Takatori Y, Kokubo T, Ninomiya S, et al. Avascular necrosis of the femoral head. Natural history and magnetic resonance imaging. J Bone Joint Surg Br 1993;75:217-221.
81. Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 2004;22:4979-4990.
82. Children's Oncology Group long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers, version 2. In: 2006. http://www.survivorshipguidelines.org.